Corrigendum to ‘Engineered multilayer ovarian tissue that secretes sex steroids and peptide hormones in response to gonadotropins’ [Biomaterials 34/10 (2013) 2412–2420]., (S0142961212013312), (10.1016/j.biomaterials.2012.11.059);Engineered multilayer ovarian tissue that secretes sex steroids and peptide hormones in response to gonadotropins

Biomaterials

Volumn 34, Issue 10, 2013, Pages 2412-2420

  Sittadjody, Sivanandane ^a   Saul, Justin M ^b   Joo, Sunyoung ^a   Yoo, James J ^a   Atala, Anthony ^a   Opara, Emmanuel C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b MIAMI UNIVERSITY   (United States)

Author keywords

Alginate; Cell based hormone replacement therapy; Encapsulation; Follicles; Multilayer microcapsules; Ovarian cells

Indexed keywords

CYTOLOGY; ENCAPSULATION; ENDOCRINOLOGY; HORMONES; LIPIDS; MICROSTRUCTURE; MULTILAYERS; PEPTIDES; PHYSIOLOGY; TISSUE;

CELL-BASED; CELL-BASED HORMONE REPLACEMENT THERAPY; FOLLICLE; HORMONE REPLACEMENT THERAPY; IN-VITRO; MULTILAYER MICROCAPSULES; OVARIAN CELL; OVARIAN TISSUE; PEPTIDE HORMONES; SEX STEROID HORMONES;

CELLS;

ACTIVIN; ALGINIC ACID; ESTRADIOL; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; PEPTIDE HORMONE; PROGESTERONE; SEX HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ENCAPSULATION; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; ENDOCRINE FUNCTION; FEMALE; GRANULOSA CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; MICROCAPSULE; NANOENCAPSULATION; NONHUMAN; OVARY; OVARY FOLLICLE; OVARY TISSUE; PRIORITY JOURNAL; PROGESTERONE RELEASE; RAT; THECA CELL;

RATTUS;

EID: 84872677529     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2024.122657     Document Type: Erratum

References (51)

1. Adashi E.Y. Endocrinology of the ovary. Hum Reprod 1994, 9(5):815-827.
2. Drummond A.E. The role of steroids in follicular growth. Reprod Biol Endocrinol 2006, 4:16.
3. Edson M.A., Nagaraja A.K., Matzuk M.M. The mammalian ovary from genesis to revelation. Endocr Rev 2009, 30(6):624-712.
4. Wierman M.E. Sex steroid effects at target tissues: mechanisms of action. Adv Physiol Educ 2007, 31(1):26-33.
5. Falck B. Site of production of oestrogen in the ovary of the rat. Nature 1959, 184(Suppl. 14):1082.
6. Falck B. Site of production of oestrogen in rat ovary as studied in micro-transplants. Acta Physiol Scand Suppl 1959, 47(163):1-101.
7. Hillier S.G., Whitelaw P.F., Smyth C.D. Follicular oestrogen synthesis: the 'two-cell, two-gonadotrophin' model revisited. Mol Cell Endocrinol 1994, 100(1-2):51-54.
8. Kobayashi M., Nakano R., Ooshima A. Immunohistochemical localization of pituitary gonadotrophins and gonadal steroids confirms the 'two-cell, two-gonadotrophin' hypothesis of steroidogenesis in the human ovary. J Endocrinol 1990, 126(3):483-488.
9. Short R.V. Ovarian steroid synthesis and secretion in vivo. Recent Prog Horm Res 1964, 20:303-340.
10. Erickson G.F., Magoffin D.A., Dyer C.A., Hofeditz C. The ovarian androgen producing cells: a review of structure/function relationships. Endocr Rev 1985, 6(3):371-399.
11. Richards J.S. Hormonal control of gene expression in the ovary. Endocr Rev 1994, 15(6):725-751.
12. Chakraborty T.R., Gore A.C. Aging-related changes in ovarian hormones, their receptors, and neuroendocrine function. Exp Biol Med 2004, 229(10):977-987.
13. Stevenson J.C. A woman's journey through the reproductive, transitional and postmenopausal periods of life: impact on cardiovascular and musculo-skeletal risk and the role of estrogen replacement. Maturitas 2011, 70(2):197-205.
14. Gambrell R.D. The menopause. Invest Radiol 1986, 21(4):369-378.
15. Gambacciani M., Monteleone P., Sacco A., Genazzani A.R. Hormone replacement therapy and endometrial, ovarian and colorectal cancer. Best Pract Res Clin Endocrinol Metab 2003, 17(1):139-147.
16. Gambacciani M., Genazzani A.R. Hormone therapy. Menopause 2003, 10(3):266-267.
17. Maclaran K., Stevenson J.C. Primary prevention of cardiovascular disease with HRT. Womens Health 2012, 8(1):63-74.
18. Stevenson J.C., Hodis H.N., Pickar J.H., Lobo R.A. HRT and breast cancer risk: a realistic perspective. Climacteric 2011, 14(6):633-636.
19. Stevenson J.C. Prevention of osteoporosis: one step forward, two steps back. Menopause Int 2011, 17(4):137-141.
20. Darrabie M.D., Kendall W.F., Opara E.C. Characteristics of Poly-L-Ornithine-coated alginate microcapsules. Biomaterials 2005, 26(34):6846-6852.
21. Khanna O., Moya M.L., Opara E.C., Brey E.M. Synthesis of multilayered alginate microcapsules for the sustained release of fibroblast growth factor-1. J Biomed Mater Res A 2010, 95(2):632-640.
22. Lim F., Sun A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980, 210(4472):908-910.
23. Opara E.C., Mirmalek-Sani S.H., Khanna O., Moya M.L., Brey E.M. Design of a bioartificial pancreas(+). J Investig Med 2010, 58(7):831-837.
24. Wong H., Chang T.M. Bioartificial liver: implanted artificial cells microencapsulated living hepatocytes increases survival of liver failure rats. Int J Artif Organs 1986, 9(5):335-336.
25. Li S.K., Hearn M.T. Isolation of thecal cells: an assessment of purity and steroidogenic potential. J Biochem Biophys Methods 2000, 45(2):169-181.
26. Magoffin D.A., Erickson G.F. Purification of ovarian theca-interstitial cells by density gradient centrifugation. Endocrinology 1988, 122(5):2345-2347.
27. Tendulkar S., Mirmalek-Sani S.H., Childers C., Saul J., Opara E.C., Ramasubramanian M.K. A three-dimensional microfluidic approach to scaling up microencapsulation of cells. Biomed Microdevices 2012, 14(3):461-469.
28. Nelson H.D., Humphrey L.L., Nygren P., Teutsch S.M., Allan J.D. Postmenopausal hormone replacement therapy: scientific review. JAMA 2002, 288(7):872-881.
29. Santos E., Zarate J., Orive G., Hernandez R.M., Pedraz J.L. Biomaterials in cell microencapsulation. Adv Exp Med Biol 2010, 670:5-21.
30. Lee K.Y., Mooney D.J. Hydrogels for tissue engineering. Chem Rev 2001, 101(7):1869-1879.
31. West E.R., Xu M., Woodruff T.K., Shea L.D. Physical properties of alginate hydrogels and their effects on in vitro follicle development. Biomaterials 2007, 28(30):4439-4448.
32. Rokstad A.M., Kulseng B., Strand B.L., Skjak-Braek G., Espevik T. Transplantation of alginate microcapsules with proliferating cells in mice: capsular overgrowth and survival of encapsulated cells of mice and human origin. Ann N Y Acad Sci 2001, 944:216-225.
33. Stabler C.L., Sambanis A., Constantinidis I. Effects of alginate composition on the growth and overall metabolic activity of betaTC3 cells. Ann N Y Acad Sci 2002, 961:130-133.
34. Rowley J.A., Madlambayan G., Mooney D.J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 1999, 20(1):45-53.
35. de V.P., Faas M.M., Strand B., Calafiore R. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials 2006, 27(32):5603-5617.
36. Orive G., Tam S.K., Pedraz J.L., Halle J.P. Biocompatibility of alginate-poly-L-lysine microcapsules for cell therapy. Biomaterials 2006, 27(20):3691-3700.
37. Ponce S., Orive G., Hernandez R., Gascon A.R., Pedraz J.L., de Haan B.J., et al. Chemistry and the biological response against immunoisolating alginate-polycation capsules of different composition. Biomaterials 2006, 27(28):4831-4839.
38. Kreeger P.K., Deck J.W., Woodruff T.K., Shea L.D. The in vitro regulation of ovarian follicle development using alginate-extracellular matrix gels. Biomaterials 2006, 27(5):714-723.
39. Xu J., Lawson M.S., Yeoman R.R., Pau K.Y., Barrett S.L., Zelinski M.B., et al. Secondary follicle growth and oocyte maturation during encapsulated three-dimensional culture in rhesus monkeys: effects of gonadotrophins, oxygen and fetuin. Hum Reprod 2011, 26(5):1061-1072.
40. Meidan R., Girsh E., Blum O., Aberdam E. In vitro differentiation of bovine theca and granulosa cells into small and large luteal-like cells: morphological and functional characteristics. Biol Reprod 1990, 43(6):913-921.
41. Portela V.M., Zamberlam G., Price C.A. Cell plating density alters the ratio of estrogenic to progestagenic enzyme gene expression in cultured granulosa cells. Fertil Steril 2010, 93(6):2050-2055.
42. Parsons-Wingerter P.A., Saltzman W.M. Growth versus function in the three-dimensional culture of single and aggregated hepatocytes within collagen gels. Biotechnol Prog 1993, 9(6):600-607.
43. Saltzman W.M., Parkhurst M.R., Parsons-Wingerter P., Zhu W.H. Three-dimensional cell cultures mimic tissues. Ann N Y Acad Sci 1992, 665:259-273.
44. Sharma R., Greenhough S., Medine C.N., Hay D.C. Three-dimensional culture of human embryonic stem cell derived hepatic endoderm and its role in bioartificial liver construction. J Biomed Biotechnol 2010, 2010:236147.
45. Weber L.M., Hayda K.N., Haskins K., Anseth K.S. The effects of cell-matrix interactions on encapsulated beta-cell function within hydrogels functionalized with matrix-derived adhesive peptides. Biomaterials 2007, 28(19):3004-3011.
46. Orisaka M., Tajima K., Tsang B.K., Kotsuji F. Oocyte-granulosa-theca cell interactions during preantral follicular development. J Ovarian Res 2009, 2(1):9.
47. Russell D.L., Robker R.L. Molecular mechanisms of ovulation: co-ordination through the cumulus complex. Hum Reprod Update 2007, 13(3):289-312.
48. Young J.M., McNeilly A.S. Theca: the forgotten cell of the ovarian follicle. Reproduction 2010, 140(4):489-504.
49. Bosc M.J., Nicolle A. Steroid productions by co-cultures of granulosa cells with inner and outer theca cells in preovulatory follicles of gonadotropin stimulated calves. J Steroid Biochem Mol Biol 1997, 62(2-3):213-221.
50. Campbell B.K., Baird D.T. Inhibin A is a follicle stimulating hormone-responsive marker of granulosa cell differentiation, which has both autocrine and paracrine actions in sheep. J Endocrinol 2001, 169(2):333-345.
51. Young J.M., McNeilly A.S. Inhibin removes the inhibitory effects of activin on steroid enzyme expression and androgen production by normal ovarian thecal cells. J Mol Endocrinol 2012, 48(1):49-60.